InvestorsHub Logo
Followers 11
Posts 292
Boards Moderated 0
Alias Born 03/11/2011

Re: lasers post# 33474

Tuesday, 10/13/2015 8:27:29 PM

Tuesday, October 13, 2015 8:27:29 PM

Post# of 48316
got it, so yes, that belongs to University of South Florida. Therefore, what Oncosec is planning to do in the future is to license the ImmunoPulse platform which might be utilized with different Interleukins in combination with a drug, in different parts of the body and for all types of cancers.